GT Biopharma, Inc. - 8-K Filing
GT Biopharma increased its Series M Convertible Preferred Stock offering from $7.45M to $7.75M and added a new investor. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 3.03 Material Modification to Rights of Security Holders, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year)
Tickers: $GTBP